<DOC>
	<DOCNO>NCT00764582</DOCNO>
	<brief_summary>Compare corneal penetration levofloxacin 1.5 % moxifloxacin 0.5 % patient undergo penetrate keratoplasty ( PK )</brief_summary>
	<brief_title>Ocular Penetration 1.5 % Levofloxacin 0.5 % Moxifloxacin During Corneal Transplant Surgery</brief_title>
	<detailed_description />
	<mesh_term>Eye Injuries , Penetrating</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Inclusion Criteria Man woman 18 year age old Scheduled corneal transplant surgery Patients must healthy enough undergo surgery Women must postmenopausal least 1 year surgically sterile incapable pregnancy Women must abstinent discretion investigator Women practice effective method birth control Women agree entry continue use method contraception throughout study Women childbearing potential must negative urine pregnancy test screen Exclusion Criteria Presence active ocular infection positive history ocular herpetic infection History severe dry eye syndrome Use contact lenses 2 week prior study duration study Received experimental drug use experimental medical device within 30 day plan start treatment Pregnant breast feed Employees investigator study center direct involvement propose study study direction investigator study center well family member employee investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Corneal penetration levofloxacin moxifloxacin</keyword>
</DOC>